European Journal of Chemistry

Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS



Main Article Content

Ahmed Abd-Alazim Mostafa

Abstract

The enantiomeric separation of warfarin (WAR) enantiomers and its hydroxy metabolites positional isomers is described in this work. The utilization of chiral chromatography coupled to Tandem mass spectrometry helps to achieve that. The developed method was able to separate R,S-warfarin and enantiomers of 4,7,10-hydroxy warfarin in human plasma. Plasma samples were processed with simple protein precipitation with acetonitrile. The chromatographic separation was done on chiral Astec Chirobiotic V column with gradient flow of 0.1% aqueous formic acid and 0.1% formic in acetonitrile:water (95:5, v:v). The mass spectroscopic detection was done via negative mode multiple reaction monitoring (MRM) on a triple quadrupole mass spectrometer coupled with positive electrospray ionization (ESI). Linearity of the method was valid over a concentration range of 125.00-0.13 µg/mL for racemic WAR, 47.000-0.088 µg/mL for racemic 4’-OH-WAR, 56.00-0.18 µg/mL for racemic 7-OH-WAR and 56.00-0.02 µg/mL for racemic 10-OH-WAR. The LLOQs were found to be 0.13 µg/mL for racemic WAR, 0.088 µg/mL for racemic 4’-OH-WAR, 0.18 µg/mL for racemic 7-OH-WAR and 0.02 µg/mL for racemic 10-OH-WAR. The method was validated for matrix effect, intra- and inter-day precision, freeze/thaw and storage stability. Accuracy and precision were within acceptable range (<15%). Enantiomeric forms of WAR and its metabolites were separated by the chiral column. Standards for R- and S-WAR identified peak 2 as S-WAR while metabolite peaks could not be definitively identified. Peak 2 for 7-OH-WAR gave higher blood levels, while the opposite applied to 10-OH-WAR.


icon graph This Abstract was viewed 1611 times | icon graph Article PDF downloaded 584 times

How to Cite
(1)
Mostafa, A. A.-A. Enantiomeric Separation and Quantitation of Warfarin and Its Metabolites in Human Plasma by LC-MS MS. Eur. J. Chem. 2016, 7, 357-362.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Bern, M. M.; Lokich, J. J.; Wallach, S. R.; Bothe, J. A.; Benotti, P. N.; Arkin, C. F.; Greco, F. A.; Huberman, M.; Moore, C. Ann. Intern. Med. 1990, 112, 423-428.
http://dx.doi.org/10.7326/0003-4819-76-3-112-6-423

[2]. Ridker, P. M.; Goldhaber, S. Z.; Danielson, E.; Rosenberg, Y.; Eby, C. S.; Deitcher, S. R.; Cushman, M.; Moll, S.; Kessler, C. M.; Elliott, C. G.; Paulson, R.; Wong, T.; Bauer, K. A.; Schwartz, B. A.; Miletich, J. P.; Bounameaux, H.; Glynn, R. J. N. Engl. J. Med. 2003, 348, 1425-1434.
http://dx.doi.org/10.1056/NEJMoa035029

[3]. Radwan, M. A.; Bawazeer, G. A.; Aloudah, N. M.; AlQuadeib, B. T.; Aboul-Enein, H. Y. J. Chromatogr. B Biomed. App. 2012, 26, 6-11.

[4]. Kaminsky, L. S.; Zhang, Z. Y. Pharmacol. Ther. 1997, 73, 67-74.
http://dx.doi.org/10.1016/S0163-7258(96)00140-4

[5]. Rettie, A. E.; Korzekwa, K. R.; Kunze, K. L.; Lawrence, R. F.; Eddy, A. C.; Aoyama, T.; Gelboin, H. V.; Gonzalez, F. J.; Trager, W. F. Chem. Res. Toxicol. 1992, 5, 54-59.
http://dx.doi.org/10.1021/tx00025a009

[6]. Scordo, M. G.; Pengo, V.; Spina, E.; Dahl, M. L.; Gusella, M.; Padrini, R. Clin. Pharmacol. Ther. 2002, 72, 702-710.
http://dx.doi.org/10.1067/mcp.2002.129321

[7]. Loebstein, R.; Yonath, H.; Peleg, D.; Almog, S.; Rotenberg, M.; Lubetsky, A.; Roitelman, J.; Harats, D.; Halkin, H.; Ezra, D. Clin. Pharmacol. Ther. 2001, 70, 159-164.
http://dx.doi.org/10.1067/mcp.2001.117444

[8]. Giuseppe, L.; Elena, R.; Antonio Maria, L.; Valerio De, S. Curr. Med. Chem. Cardiovasc. Hematol. Agents. 2004, 2, 311-326.
http://dx.doi.org/10.2174/1568016043356183

[9]. Miller, G. P.; Jones, D. R.; Sullivan, S. Z.; Mazur, A.; Owen, S. N.; Mitchell, N. C.; Radominska-Pandya, A.; Moran, J. H. Chem. Res. Toxico. 2009, 22, 1239-1245.
http://dx.doi.org/10.1021/tx900031z

[10]. Redman, A. R.; Zheng, J.; Shamsi, S. A.; Huo, J.; Kelly, E. J.; Ho, R. J. Y.; Ritchie, D. M.; Yuen, Y. H. Clin. Appl. Thromb. Hemost. 2008, 14, 29-37.
http://dx.doi.org/10.1177/1076029607304403

[11]. Piatkov, I.; Rochester, C.; Jones, T.; Boyages, S. Toxins (Basel) 2010, 2, 2584-2592.
http://dx.doi.org/10.3390/toxins2112584

[12]. Hirsh, J. Am. J. Cardiol. 1995, 75, 39B-42B.

[13]. Gübitz, G. Chromatographia 1990, 30, 555-564.
http://dx.doi.org/10.1007/BF02269804

[14]. Sekhon, B. S. Int. J. Pharmtech. Res. 2010, 2, 1584-1159.

[15]. Zuo, Z.; Wo, S. K.; Lo, C. M. Y.; Zhou, L.; Cheng, G.; You, J. H. S. J. Pharm. Biomed. Anal. 2010, 52, 305-310.
http://dx.doi.org/10.1016/j.jpba.2010.01.005

[16]. Locatelli, I.; Kmetec, V.; Mrhar, A.; Grabnar, I. J. Chromatogr. B Biomed. Sci. Appl. 2005, 818, 191-198.

[17]. Ring, P. R.; Bostick, J. M. J. Pharm. Biomed. Anal. 2000, 22, 573-581.
http://dx.doi.org/10.1016/S0731-7085(00)00232-6

[18]. Malakova, J.; Pavek, P.; Svecova, L.; Jokesova, I.; Zivny, P.; Palicka, V. J. Chromatogr. B Biomed. Sci. Appl. 2009, 877, 3226-3230.

[19]. Wang, X.; Hou, J.; Jann, M.; Hon, Y. Y.; Shamsi, S. A. J. Chromatogr. A 2013, 1271, 207-216.
http://dx.doi.org/10.1016/j.chroma.2012.11.046

[20]. Heneedak, H. M.; Salama, I.; Mostafa, S.; El-Kady, E.; El-Sadek, M. Biomed. Chrom. 2015, 29, 998-1007.
http://dx.doi.org/10.1002/bmc.3384

[21]. Mostafa, A.; Medley, G.; Roberts, D. M.; Mohamed, M. S.; Elshanawani, A. A.; Roberts, M. S.; Liu, X. J. Chromatogr. B Biomed. App. 2011, 879, 2234-2238.

[22]. Kim, S. Y.; Kang, J. Y.; Hartman, J. H.; Park, S. H.; Jones, D. R.; Yun, C. H.; Boysen, G.; Miller, G. P. Drug Metab. Lett. 2012, 6, 157-164.
http://dx.doi.org/10.2174/1872312811206030002

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).